“Immune Microenvironment in High-Grade Serous Ovarian Carcinomas: Association With Molecular Profiles and Neoadjuvant Therapy Outcome”. 2023. Voprosy Onkologii 69 (1): 74-81. https://doi.org/10.37469/0507-3758-2023-69-1-74-81.